Built on 10 years of research at the Laboratory of Biology and Applied Pharmacology (ENS Paris-Saclay/CNRS), Kimialys' patented technology pushes back the current boundaries of biodetection. Developed for gold nanoparticles and biochips, our surface chemistry optimizes the specificity and sensitivity of biological assays, by removing background noise while fine-tuning the immobilization of the ligand. Kimialys help lateral flow assay developers reduce their cost of development and production while achieving unprecedented rapid test accuracy. Kimialys' proprietary technology is also the best solution on the market for biologists that want to get the most of their Surface Plasmon Resonance (SPR) system for their in vitro analysis. Kimialys provides gold nanoparticles & biochips as well as contract development services for its customers.